Anthracycline’s Effects on Heart Rate Variability in Children with Acute Lymphoblastic Leukemia: Early Toxicity Signs—Pilot Study
Anthracycline treatments are known to cause cardiotoxic long-term side effects in cancer survivors. Recently, a decrease in heart rate variability (HRV) has been identified in these patients, signaling autonomic dysfunction and altered cardiac fitness. This study aimed at evaluating changes in HRV i...
Main Authors: | Diana R. Lazar, Simona Cainap, Dana Maniu, Cristina Blag, Madalina Bota, Florin-Leontin Lazar, Alexandru Achim, Marius C. Colceriu, Mihnea Zdrenghea |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/22/7052 |
Similar Items
-
Why Do Children with Acute Lymphoblastic Leukemia Fare Better Than Adults?
by: Alexandra Neaga, et al.
Published: (2021-08-01) -
Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01) -
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
by: Xi Zhou, et al.
Published: (2023-10-01) -
Evaluation of early-onset cardiotoxic effects of anthracyclines used during the treatment of childhood acute lymphoblastic leukemia by speckle-tracking echocardiography
by: Özlem Arman Bilir, et al.
Published: (2022-01-01) -
Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)